A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole

Clinical trial NCT05178862 · TERMINATED

Trial details

NCT number: NCT05178862
Sponsor: Scynexis, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Candidiasis, Invasive Candidemia

Start date: 2022-08-03
Primary completion: 2025-11-07
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.